Stem Cells & Wnt | 干细胞及 Wnt 通路

2-乙酰基呋喃并-1,4-萘醌

Napabucasin(BBI608)

- 98+%

奥拉替尼马来酸盐 (1208319-27-0)

Oclacitinib Maleate (PF-03394197 Maleate)

- 98+%

布隆妥珠单抗

Brontictuzumab (Anti-NOTCH1)

3-5days 95+%

万替妥单抗

Vantictumab (Anti-FZD)

3-5days 95+%

他瑞妥单抗

Tarextumab (Anti-NOTCH3)

3-5days 95+%

登赛珠单抗

Demcizumab (Anti-DLL4)

3-5days 95+%

青蒿琥酯; 青蒿脂

Artesunate

In-stock 98+%

IWP-2

N -(6-Methyl-2-benzothiazolyl)-2-[(3​,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2- d ]pyrim​idin-2-yl)thio]-acetamide

In-stock 98+%

(R)-(+)-反式-4-(1-氨基乙基)-N-(4-吡啶基)环己烷甲酰胺二盐酸盐单水合物/反-4-[(1R)-1-氨基乙基]-N-4-吡啶-环己甲酰胺盐酸盐一水合物

Y27632 HCl hydrate,(R)-(+)-trans-4-(1-Aminoethyl)-N-(4-pyridyl)cyclohexanecarboxamide Dihydrochloride Monohydrate/Y-27632 Dihydrochloride Monohydrate

- 98+%

维莫德吉

Vismodegib (GDC-0449)

In-stock 98+%

(6S,9aS)-六氢-6-[(4-羟基苯基)甲基]-8-(1-萘基甲基)-4,7-二氧代-N-(苯甲基)-2H-吡嗪并[1,2-a]嘧啶-1(6H)-甲酰胺

ICG-001(ICG 001); (S,S)-ICG 001

In-stock 98+%

托法替尼;托法替布

Tofacitinib (Tasocitinib; CP-690550)

3-5days 98+%

XAV-939

XAV-939

In-stock 98+%

WP1066

WP1066

In-stock 98+%

环巴胺(环杷明)

Cyclopamine (11-deoxojervine)

In-stock 98+%

6-[2-[4-(2,4-二氯苯基)-5-(4-甲基-1H-咪唑-2-基)嘧啶-2-基氨基]乙基氨基]吡啶-3-甲腈

Laduviglusib (CHIR-99021; CT99021)

In-stock 99+%

反式-4-[(R)-1-氨基乙基]-N-(4-吡啶基)环己烷甲酰胺二盐酸盐

Y-27632 Dihydrochloride; Y-27632 2HCl

In-stock 98+%